Browse hierarchy: [Microbiology (MI)](/submissions/MI) → [Subpart D — Serological Reagents](/submissions/MI/subpart-d%E2%80%94serological-reagents) → [21 CFR 866.3945](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3945) → OSU — Dengue Serological Reagents

# OSU · Dengue Serological Reagents

_Microbiology · 21 CFR 866.3945 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OSU

## Overview

- **Product Code:** OSU
- **Device Name:** Dengue Serological Reagents
- **Regulation:** [21 CFR 866.3945](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3945)
- **Device Class:** 2
- **Review Panel:** [Microbiology](/submissions/MI)

## Identification

Dengue virus serological reagents are devices that consist of antigens and antibodies for the detection of dengue virus and dengue antibodies in individuals who have signs and symptoms of dengue fever or dengue hemorrhagic fever. The detection aids in the clinical laboratory diagnosis of dengue fever or dengue hemorrhagic fever caused by dengue virus.

## Classification Rationale

Class II (special controls). The special control is FDA's guideline entitled “Class II Special Controls Guideline: Dengue Virus Serological Reagents.” For availability of the guideline document, see § 866.1(e).

## Special Controls

*Classification.* Class II (special controls). The special control is FDA's guideline entitled “Class II Special Controls Guideline: Dengue Virus Serological Reagents.” For availability of the guideline document, see § 866.1(e).

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN100020](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OSU/DEN100020.md) | DENV DETECT IGM CAPTURE ELISA | Inbios Intl., Inc. | Apr 8, 2011 | DENG |

## Top Applicants

- Inbios Intl., Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OSU](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/OSU)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com